FAM54B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.628000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.300800E-01
Normal-vs-Stage2
2.432800E-01
Normal-vs-Stage3
5.029800E-02
Normal-vs-Stage4
9.633200E-01
Stage1-vs-Stage2
5.051800E-01
Stage1-vs-Stage3
1.388020E-01
Stage1-vs-Stage4
4.800800E-01
Stage2-vs-Stage3
1.529850E-01
Stage2-vs-Stage4
1.666370E-01
Stage3-vs-Stage4
4.141600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.051200E-01
Normal-vs-AfricanAmerican
2.319600E-01
Normal-vs-Asian
1.326230E-01
Caucasian-vs-AfricanAmerican
7.319600E-01
Caucasian-vs-Asian
3.009800E-01
AfricanAmerican-vs-Asian
6.698600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.474600E-01
Normal-vs-Female
5.111200E-01
Male-vs-Female
2.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.508200E-01
Normal-vs-Age(41-60Yrs)
4.928400E-01
Normal-vs-Age(61-80Yrs)
3.454800E-01
Normal-vs-Age(81-100Yrs)
9.748300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.385600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.242600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.543390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.621600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.064000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.276300E-02
Normal-vs-Daily Drinker
2.999400E-01
Normal-vs-Weekly Drinker
3.062600E-01
Normal-vs-Occasional Drinker
8.469800E-01
Normal-vs-Social Drinker
8.067400E-01
Non Drinker-vs-Daily Drinker
2.622600E-01
Non Drinker-vs-Weekly Drinker
2.695000E-01
Non Drinker-vs-Occasional Drinker
1.029010E-01
Non Drinker-vs-Social Drinker
2.996100E-02
Daily Drinker-vs-Weekly Drinker
9.323600E-01
Daily Drinker-vs-Occasional Drinker
3.468200E-01
Daily Drinker-vs-Social Drinker
2.523800E-01
Weekly Drinker-vs-Occasional Drinker
3.990200E-01
Weekly Drinker-vs-Social Drinker
3.404200E-01
Occasional Drinker-vs-Social Drinker
9.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.782600E-01
Normal-vs-Grade 2
7.496800E-01
Normal-vs-Grade 3
8.330000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.832800E-01
Grade 1-vs-Grade 3
1.307610E-01
Grade 1-vs-Grade 4
4.782600E-01
Grade 2-vs-Grade 3
1.120820E-01
Grade 2-vs-Grade 4
7.496800E-01
Grade 3-vs-Grade 4
8.330000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.215000E-01
Normal-vs-NonDiabetic
4.029200E-01
Diabetic-vs-NonDiabetic
3.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.075200E-01
Normal-vs-NoPancreatitis
3.035200E-01
Pancreatitis-vs-NoPancreatitis
3.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.271600E-01
Normal-vs-N1
2.784200E-01
N0-vs-N1
6.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.774800E-01
Normal-vs-TP53-NonMutant
6.750200E-01
TP53-Mutant-vs-TP53-NonMutant
2.457400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
